Home › Funds › UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME › ABBV

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME position in ABBV

ABBVIE INC · Health Care

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME reported holding 19,665,501 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$5.14B, representing 0.78% of its reported portfolio and ranking #18 among its reported holdings. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)19.67M sh
Reported value held$5.14B
Portfolio Weight0.78%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's ABBV position evolved

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME first disclosed a stake in ABBV in Q3 2023 at 9,406,247 shares (US$1.40B). The position peaked in Q3 2026 at 19,665,501 shares, worth US$5.14B. Across 13 filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 19,665,501 shares valued at US$5.14B — an increase of 5,397,804 shares quarter over quarter.. Notable position changes include a 38% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.41M $1.40B New
Q4 2023 8.84M $1.37B Reduce
Q1 2024 8.75M $1.59B Reduce
Q2 2024 9.59M $1.65B Add
Q3 2024 10.18M $2.01B Add
Q4 2024 12.06M $2.14B Add
Q1 2025 12.77M $2.68B Add
Q2 2025 14.60M $2.71B Add
Q3 2025 12.58M $2.91B Reduce
Q4 2025 12.92M $2.95B Add
Q1 2026 14.16M $3.08B Add
Q2 2026 14.27M $3.59B Add
Q3 2026 19.67M $5.14B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME held ABBV?

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's current position in ABBV?

As of Q3 2026, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME holds 19.67M shares of ABBV (ABBVIE INC), valued at $5.14B, representing 0.78% of its reported portfolio and ranking #18.

Has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME been buying or selling ABBV?

In the latest 13F filing (Q3 2026), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased its position in ABBV. The position peaked in Q3 2026 at 19.67M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.